CRANBURY, N.J., Jan. 9, 2012 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD) today provided its business outlook and financial guidance for fiscal year 2012, including details of its strategic vision and plan. John F. Crowley, Chairman and CEO of Amicus will discuss Amicus’ corporate objectives and key milestones in a presentation at the 30th Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2012 at 8 a.m. PT (11 a.m. ET).
